European health systems balked at the nearly $2 million price tag for the gene therapy called Zynteglo, and when negotiations broke down, …
Posted inTechnology News
Patients with beta-thalassemia benefit from Bluebird gene therapy – Stat News
European health systems balked at the nearly $2 million price tag for the gene therapy called Zynteglo, and when negotiations broke down, …